Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study - PubMed (original) (raw)
Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study
Felix R Day et al. Sci Rep. 2015.
Abstract
Early puberty timing is associated with higher risks for type 2 diabetes (T2D) and cardiovascular disease in women and therefore represents a potential target for early preventive interventions. We characterised the range of diseases and other adverse health outcomes associated with early or late puberty timing in men and women in the very large UK Biobank study. Recalled puberty timing and past/current diseases were self-reported by questionnaire. We limited analyses to individuals of White ethnicity (250,037 women; 197,714 men) and to disease outcomes with at least 500 cases (~ 0.2% prevalence) and we applied stringent correction for multiple testing (corrected threshold P < 7.48 × 10(-5)). In models adjusted for socioeconomic position and adiposity/body composition variables, both in women and men separately, earlier puberty timing was associated with higher risks for angina, hypertension and T2D. Furthermore, compared to the median/average group, earlier or later puberty timing in women or men was associated with higher risks for 48 adverse outcomes, across a range of cancers, cardio-metabolic, gynaecological/obstetric, gastrointestinal, musculoskeletal, and neuro-cognitive categories. Notably, both early and late menarche were associated with higher risks for early natural menopause in women. Puberty timing in both men and women appears to have a profound impact on later health.
Figures
Figure 1. Distribution of effect sizes by quintile of menarche age for all of the 140 tested diseases and adverse health outcomes in women.
The odds ratio for each disease for each quintile is calculated relative to the middle quintile (Q3). The box in each plot represents the inter quartile range (IQR) of the effect estimates the whiskers represent the range of effects that are 1.5 × IQR beyond the IQR, odds ratios for disease more extreme than this are plotted as individual points.
Figure 2. Associations between early or late menarche timing and adverse health outcomes in women.
Displayed outcomes showed study-wise significant (P < 7.48 × 10-5) associations in any model (linear, early or late menarche). Effect estimates (± 95% CI) are shown for early (the earliest quintile) or late (the latest quintile) menarche groups compared to the middle quintile (reference group). Purple centres (with purple error bars) indicate significant associations from baseline models (adjusted for birth year, age and age squared). Green centres (with green error bars) indicate significant associations from models adjusted for socio-economic and adiposity/body composition variables (except for Obesity). Grey error bars indicate associations that did not reach study-wise significance.
Figure 3. Distribution of effect sizes for early or late relative age at voice breaking for all 119 tested diseases and adverse health outcomes in men.
The odds ratio for each disease for those with early or late voice breaking is calculated relative to the group with a normal age at voice breaking. The box in each plot represents the inter quartile range (IQR) of the effect estimates, the whiskers represent the range of effects that are 1.5 × IQR beyond the IQR, outliers more extreme than this are plotted as individual points.
Figure 4. Associations between early or late voice breaking and adverse health outcomes in men.
Displayed outcomes showed study-wise significant (P < 7.48 × 10-5) associations in any model (early or late). Effect estimates (± 95% CI) are shown for early or late voice breaking groups compared to the “about normal age” reference group). Purple centres (with purple error bars) indicate significant associations from baseline models (adjusted for birth year, age and age squared). Green centres (with green error bars) indicate significant associations from models adjusted for socio-economic and adiposity/body composition variables (except for Obesity). Grey error bars indicate associations that did not reach study-wise significance.
Comment in
- Puberty timing has profound effect on later health, study finds.
Wise J. Wise J. BMJ. 2015 Jun 18;350:h3318. doi: 10.1136/bmj.h3318. BMJ. 2015. PMID: 26092870 No abstract available.
Similar articles
- Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis.
Cheng TS, Day FR, Lakshman R, Ong KK. Cheng TS, et al. PLoS Med. 2020 Jan 6;17(1):e1003017. doi: 10.1371/journal.pmed.1003017. eCollection 2020 Jan. PLoS Med. 2020. PMID: 31905226 Free PMC article. - Age at puberty and risk of asthma: A Mendelian randomisation study.
Minelli C, van der Plaat DA, Leynaert B, Granell R, Amaral AFS, Pereira M, Mahmoud O, Potts J, Sheehan NA, Bowden J, Thompson J, Jarvis D, Davey Smith G, Henderson J. Minelli C, et al. PLoS Med. 2018 Aug 7;15(8):e1002634. doi: 10.1371/journal.pmed.1002634. eCollection 2018 Aug. PLoS Med. 2018. PMID: 30086135 Free PMC article. - Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis.
Prentice P, Viner RM. Prentice P, et al. Int J Obes (Lond). 2013 Aug;37(8):1036-43. doi: 10.1038/ijo.2012.177. Epub 2012 Nov 20. Int J Obes (Lond). 2013. PMID: 23164700 Review. - Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK Biobank.
Elmahi E, Sanghvi MM, Jones A, Aye CYL, Lewandowski AJ, Aung N, Cooper JA, Paiva JM, Lukaschuk E, Piechnik SK, Neubauer S, Petersen SE, Leeson P. Elmahi E, et al. PLoS One. 2019 Oct 23;14(10):e0223125. doi: 10.1371/journal.pone.0223125. eCollection 2019. PLoS One. 2019. PMID: 31644534 Free PMC article. - Public health implications of altered puberty timing.
Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, Sharpe RM, Skakkebaek NE, Toppari J. Golub MS, et al. Pediatrics. 2008 Feb;121 Suppl 3:S218-30. doi: 10.1542/peds.2007-1813G. Pediatrics. 2008. PMID: 18245514 Review.
Cited by
- Alternate-day fasting delays pubertal development in normal-weight mice but prevents high-fat diet-induced obesity and precocious puberty.
Ullah R, Xue C, Wang S, Qin Z, Rauf N, Zhan S, Khan NU, Shen Y, Zhou YD, Fu J. Ullah R, et al. Nutr Diabetes. 2024 Oct 4;14(1):82. doi: 10.1038/s41387-024-00335-w. Nutr Diabetes. 2024. PMID: 39366955 Free PMC article. - Early puberty: a review on its role as a risk factor for metabolic and mental disorders.
Sun Y, Liu H, Mu C, Liu P, Hao C, Xin Y. Sun Y, et al. Front Pediatr. 2024 Sep 12;12:1326864. doi: 10.3389/fped.2024.1326864. eCollection 2024. Front Pediatr. 2024. PMID: 39328587 Free PMC article. Review. - Genetic associations with disease in populations with Indigenous American ancestries.
Vicuña L. Vicuña L. Genet Mol Biol. 2024 Sep 9;47Suppl 1(Suppl 1):e20230024. doi: 10.1590/1678-4685-GMB-2023-0024. eCollection 2024. Genet Mol Biol. 2024. PMID: 39254840 Free PMC article. - Alterations in the gut microbiota community are associated with childhood obesity and precocious puberty.
Wang L, Yi Q, Xu H, Liu H, Tan B, Deng H, Chen Y, Wang R, Tang F, Cheng X, Zhu J. Wang L, et al. BMC Microbiol. 2024 Aug 24;24(1):311. doi: 10.1186/s12866-024-03461-8. BMC Microbiol. 2024. PMID: 39182062 Free PMC article. - Genetic and non-genetic factors in prediction of early pubertal development in Chinese girls.
Li W, Du Y, Feng L, Song P, Wang L, Zhang S, Li W, Zhu D, Liu H. Li W, et al. Front Endocrinol (Lausanne). 2024 Jul 1;15:1413528. doi: 10.3389/fendo.2024.1413528. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39010901 Free PMC article.
References
- Sorensen K. et al. Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Hormone research in paediatrics 77, 137–145, doi:10.1159/000336325 (2012). - PubMed
- Harrington J. & Palmert M. R. Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. The Journal of clinical endocrinology and metabolism 97, 3056–3067, doi:10.1210/jc.2012-1598 (2012). - PubMed
- Parent A. S. et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev 24, 668–693 (2003). - PubMed
- Prentice P. & Viner R. M. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. International journal of obesity 37, 1036–1043, doi:10.1038/ijo.2012.177 (2013). - PubMed
Publication types
MeSH terms
Grants and funding
- 093707/Wellcome Trust/United Kingdom
- MC_QA137853/MRC_/Medical Research Council/United Kingdom
- MC_U106179472/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/2/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous